BBNX (Beta Bionics, Inc. Common Stock) Stock Analysis - Financials

Beta Bionics, Inc. Common Stock (BBNX) is a publicly traded Healthcare sector company. As of May 21, 2026, BBNX trades at $10.11 with a market cap of $418.88M and a P/E ratio of 0.00. BBNX moved +7.43% today. Year to date, BBNX is -65.81%; over the trailing twelve months it is -36.17%. Its 52-week range spans $8.80 to $32.71. Analyst consensus is strong buy with an average price target of $19.00. Rallies surfaces BBNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BBNX's key financials?

BBNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBNX recently traded at $10.11. Market cap is $418.88M. P/E ratio is 0.00. Revenue is $0.

BBNX Key Metrics

Key financial metrics for BBNX
MetricValue
Price$10.11
Market Cap$418.88M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$32.71
52-Week Low$8.80
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest BBNX News

Recent BBNX Insider Trades

  • Hopman Mark sold 353 (~$4.08K) on Mar 4, 2026.
  • Hopman Mark sold 834 (~$10.31K) on Mar 2, 2026.
  • Russell Steven Jon sold 1.03K (~$12.68K) on Mar 2, 2026.

BBNX Analyst Consensus

8 analysts cover BBNX: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.00.

Common questions about BBNX

What are BBNX's key financials?
BBNX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BBNX recently traded at $10.11. Market cap is $418.88M. P/E ratio is 0.00. Revenue is $0.
Is BBNX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBNX. It does not provide personalized investment advice.
BBNX

BBNX